Read More
After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.
I don't follow pharmaceutical companies much. Occasionally you can find nice ones that come up with a discovery (drug, method). Unfortunately, I've been burned by such startups. I don't know $CVS but I might look into a pharmaceutical company.